-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 20th, the Geneva Medicines Patent Pool announced that it had signed an agreement with 27 generic drug companies to produce Merck's oral COVID-19 antiviral drug molnupiravir, which will promote the use of this new crown oral drug at an acceptable burden for patients around the world
According to interim Phase III data, molnupiravir significantly reduced hospitalization or mortality